Brief: Tandem Diabetes Care Q2 Gross Margin 51%
01/08/2024 21:05
Aug 01 (Reuters) - Tandem Diabetes Care Q2 operating income USD -30.8 million. * Q2 adjusted operating income USD -30.9 million vs. IBES estimate USD -38 million * Q2 net income USD -30.8 million * Q2 adjusted net income USD -30.9 million vs. IBES estimate USD -34.9 million * outlook FY adjusted sales USD 885-892 million
Recent news on Tandem Diabetes Care
See all newsU.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Tandem Diabetes Care, Inc. reports results for the quarter ended June 30 - Earnings Summary